CGN Mining Company Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares CGN Mining Company Ltd with three other
companies in this sector in Hong Kong:
Ascletis Pharma Inc
sales of 196.90 million Hong Kong Dollars [US$25.35 million]
Tianda Pharmaceuticals Ltd
(361.55 million Hong Kong Dollars [US$46.54 million]
of which 100%
was Pharmaceutical and Biotechnology Busines), and
Uni-Bio Science Group Limited
(135.26 million Hong Kong Dollars [US$17.41 million]
of which 77%
was In-house Biological Pharmaceutical Produ).
CGN Mining Company Ltd reported sales of HK$362.03 million (US$46.60 million)
December of 2018.
decrease of 2.9%
versus 2017, when the company's sales were HK$372.79 million.
Contributing to the drop in overall sales was the 2.9% decline
in Uranium Trading, from HK$370.72 million to HK$359.92 million.
However, these declines were partially offset by the increase in sales of
Property Investment (up 2.2% to HK$2.12 million)